Elon Musk Says He Prefers Lilly’s Mounjaro over Novo’s Ozempic
An X post from Elon Musk on Wednesday highlighted Tesla CEO's newfound preference for Eli Lilly's weight loss therapy Mounjaro over Novo Nordisk's rival product Ozempic.Known as tirzepatide and semaglutide in generic terms, Mounjaro and Ozempic belong to a new class of diabetes drugs called GLP-1s, marketed as Zepbound and Wegovy for weight loss, respectively."Like Cocaine Bear, but Santa and Ozempic!" Musk said, dressed as Santa Claus in a post titled "Ozempic Santa."In response to a questio